CRT 2025 Insights: Paclitaxel-Coated Balloon vs. Uncoated Balloon for Coronary In-Stent Restenosis - Two Year Outcomes of the AGENT IDE Trial | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

CRT 2025 Insights

CRT 2025 Insights: Paclitaxel-Coated Balloon vs. Uncoated Balloon for Coronary In-Stent Restenosis - Two Year Outcomes of the AGENT IDE Trial

By CRT 2025 Insights FEATURING Jeffrey Moses

By CRT 2025 Insights FEATURING Jeffrey Moses

320 views

March 27, 2025

Comments 0

Login to view comments. Click here to Login